Form D · Other Investment Fund
USCGIM Andira Medicine LLC
San Francisco, CA · CIK 0001989904
Offering snapshot reported Aug 17, 2023 · SEC filing
- Reported sold
- $100K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 17, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2023 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06c, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490078
8% CASH AND * 8% WARRANTS FOR ANY PLACEMENTS
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| US Capital Global Securities LLC | 169544 |
Source: Form D, filed Aug 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Sweeney | Executive, Promoter |
| Charles Towle | Executive, Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1 Ferry Building Suite 201
San Francisco, CA, 94111
San Francisco, CA, 94111